R&D

Showing 15 posts of 146 posts found.

Pharma creates non-profit R&D organisation

September 21, 2012
Research and Development, Sales and Marketing Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Co, GlaxoSmithKline, Johnson & Johnson, Pfizer, R&D, Roche Genentech, Sanofi, TransCelerate BioPharma, biopharma

Ten biopharma companies have formed TransCelerate BioPharma Inc, a not-for-profit organisation using money and personnel from each firm, with a …

johnson and johnson image

J&J sets up life science centres

September 19, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing J&J, JJ, R&D, innovation

Johnson & Johnson is to set up what it calls regional innovation centres in a bid to speed up the …

UCB image

UCB opens Belgian pilot plant

September 17, 2012
Manufacturing and Production Amgen, Belgium, R&D, UCB

UCB has officially opened a new pilot biotech plant at its Braine-L’Alleud site in Belgium.The 5,100 sq. m. facility – …

Acino plant opens to serve Bayer contraceptive patch needs

August 14, 2012
Manufacturing and Production Acino, Bayer, R&D, Swiss, contraceptive

Acino has officially opened its new manufacturing facility for transdermal patch products in Miesbach, Germany, which it says makes it …

Novartis pledges to maintain R&D presence in Horsham

August 14, 2012
Manufacturing and Production, Research and Development Horsham, NIBR, Novartis, R&D, cuts

Novartis has confirmed that it intends to maintain a presence at its site in Horsham, UK, which has already seen …

Avastin image

Avastin sees success in brain cancer trial

August 13, 2012
Research and Development, Sales and Marketing R&D, avastin, brain cancer

A late-stage study has shown that Roche’s oncology drug Avastin, when added to standard therapy, can help people with brain …

Pfizer image

Torisel-Avastin combo fails in kidney cancer

August 13, 2012
Research and Development, Sales and Marketing R&D, Sutent, Torisel, avastin, failure, rcc

Combining Pfizer’s Torisel and Roche’s Avastin does not increase survival rates for advanced kidney cancer patients. This is according to …

Pfizer Sandwich image

Pfizer Sandwich site sold to private consortium

August 3, 2012
Business Services, Research and Development, Sales and Marketing Jobs, Pfizer, R&D, Sandwich, cuts

The Sandwich Discovery Park in Kent has found new owners, 18 months after Pfizer decided to pull out from the …

Government to harness NHS patient data for research use

August 2, 2012
Sales and Marketing NHS, R&D, UK, david cameron, innovation, real world data

The UK government will change the NHS Constitution in order to allow patients’ data to be used for research purposes. …

Astrazeneca image

AstraZeneca launches virtual research laboratory

July 31, 2012
Medical Communications Assay Depot, AstraZeneca, R&D, virtual

AstraZeneca and partner Assay Depot have launched a virtual research laboratory aimed at helping its scientists create R&D collaborations. The …

Parexel’s BioPharm Unit to aid smaller R&D firms

July 25, 2012
Research and Development Parexel, R&D, biotech

Parexel has launched the Parexel BioPharm Unit – a new division focused on the needs of small and mid-sized biopharma …

gsk image

GSK raises stake in Amicus for Fabry drug

July 18, 2012
Research and Development, Sales and Marketing Amicus, Fabry, GSK, R&D

GlaxoSmithKline is to increase ownership in Amicus Therapeutics as the firms extend their collaboration to find a new drug for …

Human Genome Sciences image

Glaxo seals $3 billion acquisition of HGS

July 17, 2012
Business Services, Research and Development, Sales and Marketing Benlysta, GSK, Human Genome Sciences, R&D

GlaxoSmithKline has finally sealed the acquisition of Human Genome Sciences, the company with which it co-markets lupus treatment Benlysta.  The …

Actelion image

Jobs under threat in Actelion cost saving

July 12, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Actelion, R&D, Tracleer, cuts

Swiss speciality pharmaceutical company Actelion has unveiled a new cost saving plan which could include the loss of 260 jobs …

R&D, East & West: Lilly invests in its global research network

July 10, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Asia, China, R&D, diabetes, lilly

Eli Lilly officially opened its new research facilities at its R&D base in Erl Wood in Surrey in April. The …

The Gateway to Local Adoption Series

Latest content